Rho/Rho-Kinase Pathway in the Brainstem Contributes to Hypertension Caused by Chronic Nitric Oxide Synthase Inhibition
- 1 February 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hypertension
- Vol. 43 (2), 156-162
- https://doi.org/10.1161/01.hyp.0000114602.82140.a4
Abstract
Central nervous system mechanisms are involved in hypertension caused by chronic inhibition of nitric oxide (NO) synthesis. Chronic inhibition of NO synthesis might also activate the Rho/Rho-kinase pathway in the vasculature. We recently demonstrated that activation of the Rho/Rho-kinase pathway in the nucleus tractus solitarii (NTS) contributes to hypertensive mechanisms in spontaneously hypertensive rats. The aim of the present study was to determine whether activation of this pathway also contributes to neurogenic hypertensive mechanisms caused by chronic NO synthesis inhibition. The NO synthase inhibitor N ω -nitro- l -arginine methyl ester ( l -NAME) was administered to Wistar-Kyoto rats in their drinking water (1 mg/mL) for 2 weeks. Bilateral microinjection of Y-27632, a specific Rho-kinase inhibitor, into the NTS elicited decreases in arterial pressure, heart rate, and renal sympathetic nerve activity in control rats and l -NAME–treated rats. The magnitude of the decrease, however, was significantly greater in l -NAME–treated than in control rats. In another group of rats, the specific Rho-kinase inhibitor, Y-27632, was administered intracisternally for 2 weeks with a mini-osmotic pump from the beginning of treatment with l -NAME. Y-27632 co-treatment significantly attenuated the increase in arterial pressure. Furthermore, the expression level of membranous RhoA and phosphorylation of the target proteins of Rho-kinase, the ERM (ezrin, radixin, moesin) family members, was significantly greater in l -NAME–treated rats than in control rats. These results indicate that activation of the Rho/Rho-kinase pathway in the NTS contributes to neurogenic hypertension caused by chronic NO synthase inhibition.Keywords
This publication has 17 references indexed in Scilit:
- p250GAP, a Novel Brain-enriched GTPase-activating Protein for Rho Family GTPases, Is Involved in theN-Methyl-d-aspartate Receptor SignalingMolecular Biology of the Cell, 2003
- Rho/Rho-Kinase Pathway in Brain Stem Contributes to Blood Pressure Regulation via Sympathetic Nervous SystemCirculation Research, 2003
- Structural Changes in AMPA-Receptive Neurons in the Nucleus of the Solitary Tract of Spontaneously Hypertensive RatsHypertension, 2003
- Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertensionThe FASEB Journal, 2001
- Distribution of Rho-Kinase in the Bovine BrainBiochemical and Biophysical Research Communications, 1999
- Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail AssociationThe Journal of cell biology, 1998
- Increased blood pressure in rats after long-term inhibition of the neuronal isoform of nitric oxide synthase.JCI Insight, 1997
- The Role of Nitric Oxide in the Central Control of Blood PressureBiochemical and Biophysical Research Communications, 1995
- The Central Effects of a Nitric Oxide Synthase Inhibitor (Nω- Nitro - L - Arginine) on Blood Pressure and Plasma ReninClinical and Experimental Hypertension, 1993
- Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.Hypertension, 1992